J&J Loses Bid to Block Samsung Bioepis Second Stelara Biosimilar

A federal judge rejected Johnson & Johnson’s bid to block a move by Samsung Bioepis to launch an additional biosimilar to J&J’s Stelara with a private label.

Judge Georgette Castner for the US District Court for the District of New Jersey denied Monday J&J’s motion for preliminary injunction that would have blocked Samsung’s additional biosimilar of Stelara, on top of the one it’s allowed to launch under an agreement with J&J.

The drugmaker in February filed a complaint against Samsung alleging it breached an agreement with J&J that prohibited Samsung from sub-licensing its rights to certain parties to launch ...